Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A.

Genes Dev. 2009 Dec 15;23(24):2806-11. doi: 10.1101/gad.1872909.

2.

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.

Musilova K, Mraz M.

Leukemia. 2015 May;29(5):1004-17. doi: 10.1038/leu.2014.351. Epub 2014 Dec 26. Review.

PMID:
25541152
3.

[Oncogenic and tumour suppressor microRNAs].

Finoux AL, Chartrand P.

Med Sci (Paris). 2008 Dec;24(12):1049-54. doi: 10.1051/medsci/200824121049. Review. French.

4.

mir-17-92, a cluster of miRNAs in the midst of the cancer network.

Olive V, Jiang I, He L.

Int J Biochem Cell Biol. 2010 Aug;42(8):1348-54. doi: 10.1016/j.biocel.2010.03.004. Epub 2010 Mar 19. Review.

5.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
6.

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Tao J, Zhao X, Tao J.

Cell Cycle. 2014;13(2):191-8. doi: 10.4161/cc.27646. Epub 2014 Jan 6. Review.

7.

Role of microRNA in the pathogenesis of malignant lymphoma.

Tagawa H, Ikeda S, Sawada K.

Cancer Sci. 2013 Jul;104(7):801-9. doi: 10.1111/cas.12160. Epub 2013 Apr 29. Review.

8.

The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25.

Khuu C, Utheim TP, Sehic A.

Scientifica (Cairo). 2016;2016:1379643. doi: 10.1155/2016/1379643. Epub 2016 Apr 4. Review.

9.
10.

Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer.

Fuziwara CS, Kimura ET.

Front Med (Lausanne). 2015 Sep 8;2:64. doi: 10.3389/fmed.2015.00064. eCollection 2015. Review.

11.

Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation.

Lai M, Xiao C.

Int Immunopharmacol. 2015 Oct;28(2):854-8. doi: 10.1016/j.intimp.2015.03.041. Epub 2015 Apr 11. Review.

Supplemental Content

Support Center